Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-17
SponsorDokuz Eylul University

About this trial

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections".

These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit

The child has a diagnosis of hematological or oncological cancer

The child's age range is between 1 and 17

Having a port catheter inserted and no early complications have occurred

Disqualifiers

Have a systemic infection.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Chlorhexidine Dressing

    Device

    Transparent catheter cover with Chlorhexidine (3M™ CHG Tegaderm™)

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: Care bundle approach with Chlorhexidine DressingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Central line-associated bloodstream infections

defined as the recovery of a pathogen from a blood culture in a patient who had a central line at the time of infection or within 48 hours before the development of infection

Time frame
during the intervention, up to 1 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dokuz Eylul University

Lead sponsor

Afyonkarahisar Health Science University

Collaborator